首页> 外文期刊>Photodiagnosis and Photodynamic Therapy >The sustaining of fluorescence in photodynamic diagnosis after the administration of 5-aminolevulinic acid in carcinogen-induced bladder cancer orthotopic rat model and urothelial cancer cell lines
【24h】

The sustaining of fluorescence in photodynamic diagnosis after the administration of 5-aminolevulinic acid in carcinogen-induced bladder cancer orthotopic rat model and urothelial cancer cell lines

机译:在致癌膀胱癌原位大鼠模型和尿路上癌细胞系中5-氨基乙酰丙酸施用5-氨基乙酰丙酸后的光动力诊断中的荧光

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The administration of 5-aminolevulic acid hydrochloride (5-ALA & sdot;HCl) 3 h (range: 2-4 h) before photodynamic diagnosis (PDD) is recommended for detecting bladder tumors. However, there is insufficient evidence on the time duration for the fluorescence of PDD after oral administration of 5-ALA. We investigated the sustainability of the photodynamic effect and protoporphyrinIX (PpIX) after 5-ALA administration in a carcinogen-induced bladder tumor rat model and bladder cancer cell lines. Methods: The carcinogen-induced bladder tumor orthotopic rat model was established by the administration of Nbutyl-N-(4-hydroxybutyl) nitrosamine. Results: Red fluorescence was visible 2-8 h after the oral administration of 5-ALA in the carcinogen-induced bladder tumor rat model. Plasma and intratissue PpIX (nM) progressed to a higher level at 2 h and remained almost constant 2-8 h after oral administration of 5-ALA. The peak fluorescence intensity of PpIX was observed 3-4 h after the administration of 5-ALA in bladder cancer cell lines. The accumulated PpIX remained for 4 h after the removal of 5-ALA in UMUC3 cells. It was not clearly visible 3 h after the removal of 5-ALA in MGHU3 and T24 cells. The expression level of ferrochelatase was significantly lower in UMUC3 cells than in other cells. Our findings suggest that 5-ALA-assisted PDD (ALA-PDD) can aid in detecting non-muscle-invasive bladder cancer 2-8 h after 5-ALA administration. Conclusion: Urologists might not be required to make excess effort to start ALA-PDD-assisted transurethral resection of bladder tumor after the administration of 5-ALA.
机译:背景:在光动力学诊断(PDD)之前,向施用5-氨基酸盐酸盐(5-Ala⋅ HCl)3 H(范围:2-4小时)以检测膀胱肿瘤。然而,在口服施用5-ALA后PDD荧光的持续时间存在不足的证据。我们研究了在致癌癌肿瘤大鼠模型和膀胱癌细胞中5 Ala给药后光动力学效应和Proporporphylinix(PPIX)的可持续性。方法:通过施用Nbutyl-N-(4-羟基丁基)亚硝胺来确定致癌膀胱肿瘤原位大鼠模型。结果:在致癌物诱导的膀胱肿瘤大鼠模型中,5 Ala在口服施用后,红色荧光是可见的2-8小时。等离子体和肝癌PPIX(NM)在2小时的含量​​下进化到较高水平,并且在口服施用5 ALA后几乎保持在2-8小时。在膀胱癌细胞系中施用5 Ala后,观察PPIX的峰值荧光强度3-4小时。在UMUC3细胞中除去5 ALA后,累积的PPIX保持4小时。在MGHU3和T24细胞中除去5 ALA后,在3小时内没有清晰可见。 UMUC3细胞中铁素酶的表达水平显着低于其他细胞。我们的研究结果表明,5 - ALA辅助PDD(ALA-PDD)可以帮助检测5- ALA给药后2-8小时的非肌肉侵入性膀胱癌。结论:泌尿科医生可能不需要多余的努力,在施用5艾拉后开始膀胱肿瘤的Ala-PDD辅助经尿道切除。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号